A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis

A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	McMullin, M, Mead, A, Ali, S, Cargo, C, Chen, F, Ewing, J, Garg, M, Godfrey, A, Knapper, S, McLornan, D, Nangalia, J, Sekhar, M, Wadelin, F, Harrison, C
Μορφή:	Journal article
Έκδοση:	Wiley 2018

Παρόμοια τεκμήρια

A guideline for the diagnosis and management of polycythaemia vera. A British Society for haematology guideline
ανά: McMullin, M, κ.ά.
Έκδοση: (2018)

Polycythaemia vera and central sleep apnoea.
ανά: Stradling, JR, κ.ά.
Έκδοση: (1980)

Profile of polycythaemia vera in South Western Nigeria
ανά: Patrick Olanrewaju Osho, κ.ά.
Έκδοση: (2022-01-01)

Improvement in polycythaemia vera after parathyroidectomy for primary hyperparathyroidism
ανά: Pavai Sthaneshwar, κ.ά.
Έκδοση: (2023-10-01)

Evaluation of erythrocytapheresis compared to phlebotomy in polycythaemia vera patients
ανά: Sergio Cabibbo, κ.ά.
Έκδοση: (2024-10-01)

Splenic Infarctions in Polycythaemia Vera are Not Always a Catastrophe
ανά: ELMustafa Abdalla, κ.ά.
Έκδοση: (2022-06-01)

Feasibility of recruitment of patients withMyeloproliferative Neoplasms into the TAPfunded TAMARIN study
ανά: Harrison, C, κ.ά.
Έκδοση: (2018)

Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline
ανά: McLornan, DP, κ.ά.
Έκδοση: (2023)

Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)
ανά: Jumoke Okikiolu, κ.ά.
Έκδοση: (2023-01-01)

MTAP-related increased erythroblast proliferation as a mechanism of polycythaemia vera
ανά: Chartsiam Tipgomut, κ.ά.
Έκδοση: (2021-11-01)

Longitudinal trends of peripheral blood counts in polycythaemia vera and essential thrombocythemia patients in the UK
ανά: Lewis Carpenter, κ.ά.
Έκδοση: (2022-08-01)

Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamide
ανά: Abhinav Mathur, κ.ά.
Έκδοση: (2022-11-01)

Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice
ανά: Shanti Amé, κ.ά.
Έκδοση: (2023-08-01)

Erythrocytosis associated with a novel missense mutation in the BPGM gene.
ανά: Petousi, N, κ.ά.
Έκδοση: (2014)

A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders
ανά: Bee, P.C., κ.ά.
Έκδοση: (2010)

Allogeneic stem cell transplantation for myelofibrosis in 2012.
ανά: McLornan, D, κ.ά.
Έκδοση: (2012)

Identification of high oxygen affinity hemoglobin variants in the investigation of patients with erythrocytosis
ανά: Melanie J. Percy, κ.ά.
Έκδοση: (2009-09-01)

Ruxolitinib versus best available therapy for polycythemia vera intolerant or resistant to hydroxycarbamide in a randomized trial
ανά: Harrison, CN, κ.ά.
Έκδοση: (2023)

P1001: DNMT3A/TET2/ASXL1 MUTATIONS DETERMINE THROMBOTIC RISK IN POLYCYTHAEMIA VERA
ανά: A. Segura Diaz, κ.ά.
Έκδοση: (2022-06-01)

Polyglobulia Masquerading as Polycythaemia Vera Presenting as Superior Mesenteric Vein Thrombosis: A Case Report
ανά: Janhavi Nitin Mahajan, κ.ά.
Έκδοση: (2022-10-01)

Development and validation of a sequential two-step algorithm for the screening of individuals with potential polycythaemia vera
ανά: Miguel Piris-Villaespesa, κ.ά.
Έκδοση: (2021-01-01)

The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels
ανά: Melanie J. Percy, κ.ά.
Έκδοση: (2007-12-01)

JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis
ανά: Luz Martínez-Avilés, κ.ά.
Έκδοση: (2007-12-01)

Screening for Latent Polycythemia Vera in Renal Cell Carcinoma–Associated Erythrocytosis
ανά: Stephen E. Langabeer
Έκδοση: (2023-04-01)

Potential limitations of diagnostic standard codes to distinguish polycythemia vera and secondary erythrocytosis
ανά: Alanna Barrios-Ruiz, κ.ά.
Έκδοση: (2022-03-01)

Recurrent Episodes of Angioedema as Presenting Feature of JAK2-Positive Myeloproliferative Disorder Consistent with Polycythaemia Vera
ανά: Laith Al-Azrai, κ.ά.
Έκδοση: (2021-07-01)

Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations
ανά: Camps, C, κ.ά.
Έκδοση: (2016)

The janus kinase 2 (JAK2) mutation: A review of its role in polycythaemia vera and other myeloproliferative disorders
ανά: M U Nwagu
Έκδοση: (2011-01-01)

Guideline for the investigation and management of eosinophilia
ανά: Butt, N, κ.ά.
Έκδοση: (2017)

Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to Date
ανά: Bassiony S, κ.ά.
Έκδοση: (2020-09-01)

Ropeginterferon alfa-2b shows anti-polycythaemia vera activity without causing clinically significant anaemia
ανά: Keita Kirito, κ.ά.
Έκδοση: (2024-07-01)

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.
ανά: Campbell, P, κ.ά.
Έκδοση: (2005)

Equivalence of BCSH and WHO diagnostic criteria for ET
ανά: Harrison, C, κ.ά.
Έκδοση: (2016)

Serum erythropoietin in the evaluation of erythrocytosis: How much does it contribute to the diagnosis of polycythemia vera?
ανά: Ruchi Gupta, κ.ά.
Έκδοση: (2023-01-01)

Cerebral venous sinus thrombosis in polycythaemia.
ανά: Thomson, D, κ.ά.
Έκδοση: (2008)

Cerebral venous sinus thrombosis in JAK2 V617F positive polycythaemia vera presenting as a haemorrhagic stroke
ανά: N. T. Weerasinghe, κ.ά.
Έκδοση: (2021-12-01)

Real-World Clinical Characterisation of Polycythaemia Vera Patients from a Prospective Registry in Portugal: Is Resistance to Hydroxyurea a Reality?
ανά: Maria Sarmento, κ.ά.
Έκδοση: (2023-09-01)

A Difficult Case in Clinical Practice: Combined Polycythaemia Vera and Protein S Deficiency in a Patient with both Thrombotic and Bleeding Complications
ανά: Sushanth Wattal, κ.ά.
Έκδοση: (2018-04-01)

Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations
ανά: Carme Camps, κ.ά.
Έκδοση: (2016-11-01)

Ruxolitinib induces changes in histone modification status in patients entered into the MAJIC clinical trial
ανά: McPherson, S, κ.ά.
Έκδοση: (2018)